Aging
Navigate
Submit an Article
Research Paper|Volume 13, Issue 9|pp. 12514–12525
Capsanthin induces G1/S phase arrest, erlotinib-sensitivity and inhibits tumor progression by suppressing EZH2-mediated epigenetically silencing of p21 in triple-negative breast cancer cells
Back to articleFigure 6(6 of 6)
100%
Figure 6
Figure 6.Schematic illustration depicting the roles of capsanthin in suppressing tumor progression of TNBC.